loadpatents
name:-0.039896965026855
name:-0.025820016860962
name:-0.018317937850952
West; James William Patent Filings

West; James William

Patent Applications and Registrations

Patent applications and USPTO patent grants for West; James William.The latest application filed is for "anti-pdl1 antibodies, activatable anti-pdl1 antibodies, and methods of use thereof".

Company Profile
19.24.37
  • West; James William - Bend OR
  • West; James William - South San Francisco CA
  • West; James William - San Mateo CA
  • - Bend OR US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Anti-pdl1 Antibodies, Activatable Anti-pdl1 Antibodies, And Methods Of Use Thereof
App 20220298245 - West; James William ;   et al.
2022-09-22
Protease-resistant Systems For Polypeptide Display And Methods Of Making And Using Thereof
App 20220235351 - La Porte; Sherry Lynn ;   et al.
2022-07-28
Anti-CD40 antibodies and uses thereof
Grant 11,306,149 - Barnhart , et al. April 19, 2
2022-04-19
Activatable Anti-CTLA-4 Antibodies and Uses Thereof
App 20220089734 - TIPTON; Kimberly Ann ;   et al.
2022-03-24
Protease-resistant systems for polypeptide display and methods of making and using thereof
Grant 11,198,864 - La Porte , et al. December 14, 2
2021-12-14
Matrix Metalloprotease-cleavable And Serine Protease-cleavable Substrates And Methods Of Use Thereof
App 20210355208 - MOORE; Stephen James ;   et al.
2021-11-18
Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of use thereof
Grant 11,174,316 - West , et al. November 16, 2
2021-11-16
Matrix Metalloprotease-cleavable And Serine Protease-cleavable Substrates And Methods Of Use Thereof
App 20210347886 - MOORE; Stephen James ;   et al.
2021-11-11
Multispecific antibodies, multispecific activatable antibodies and methods of using the same
Grant 11,161,906 - Lowman , et al. November 2, 2
2021-11-02
Modified Antibody Compositions, Methods Of Making And Using Thereof
App 20210284721 - Stagliano; Nancy Elizabeth ;   et al.
2021-09-16
Activatable anti-CTLA-4 antibodies and uses thereof
Grant 11,117,968 - Tipton , et al. September 14, 2
2021-09-14
Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof
Grant 11,046,759 - Moore , et al. June 29, 2
2021-06-29
Anti-pd-1 Antibodies, Activatable Anti-pd-1 Antibodies, And Methods Of Use Thereof
App 20210179713 - Tipton; Kimberly Ann ;   et al.
2021-06-17
Protease-resistant systems for polypeptide display and methods of making and using thereof
Grant 10,947,531 - La Porte , et al. March 16, 2
2021-03-16
Activatable Antibodies That Bind Epidermal Growth Factor Receptor And Methods Of Use Thereof
App 20210023243 - Lowman; Henry Bernard ;   et al.
2021-01-28
Methods of treatment using activatable anti-EGFR antibodies
Grant 10,875,913 - Stagliano , et al. December 29, 2
2020-12-29
Anti-cd40 Antibodies And Uses Thereof
App 20200339700 - BARNHART; Bryan C. ;   et al.
2020-10-29
Activatable Antibodies That Bind Interleukin-6 Receptor And Methods Of Use Thereof
App 20200339694 - West; James William ;   et al.
2020-10-29
Protease-resistant Systems For Polypeptide Display And Methods Of Making And Using Thereof
App 20200339976 - La Porte; Sherry Lynn ;   et al.
2020-10-29
Anti-cd166 Antibodies, Activatable Anti-cd166 Antibodies, And Methods Of Use Thereof
App 20200291113 - WEST; James William ;   et al.
2020-09-17
Anti-CD166 antibodies, activatable anti-CD166 antibodies, and methods of use thereof
Grant 10,745,481 - West , et al. A
2020-08-18
Anti-pdl1 Antibodies, Activatable Anti-pdl1 Antibodies, And Methods Of Use Thereof
App 20200231677 - West; James William ;   et al.
2020-07-23
Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof
Grant 10,709,799 - Lowman , et al.
2020-07-14
Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of use thereof
Grant 10,669,339 - West , et al.
2020-06-02
Activatable antibodies that bind interleukin-6 receptor and methods of use thereof
Grant 10,611,845 - West , et al.
2020-04-07
Anti-CD166 antibodies, activatable anti-CD166 antibodies, and methods of use thereof
Grant 10577420 -
2020-03-03
Anti-PD1 antibodies, activatable anti-PD1 antibodies, and methods of use thereof
Grant 10,513,558 - Tipton , et al. Dec
2019-12-24
Anti-pdl1 Antibodies, Activatable Anti-pdl1 Antibodies, And Methods Of Use Thereof
App 20190382493 - West; James William ;   et al.
2019-12-19
Anti-jagged 1/jagged 2 Cross-reactive Antibodies, Activatable Anti-jagged Antibodies And Methods Of Use Thereof
App 20190367589 - WEST; James William ;   et al.
2019-12-05
Activatable Anti-CTLA-4 Antibodies and Uses Thereof
App 20190359714 - TIPTON; Kimberly Ann ;   et al.
2019-11-28
Matrix Metalloprotease-cleavable And Serine Protease-cleavable Substrates And Methods Of Use Thereof
App 20190241652 - Moore; Stephen James ;   et al.
2019-08-08
Anti-PDL1 antibodies, activatable anti-PDL1 antibodies, and methods of thereof
Grant 10,336,824 - West , et al.
2019-07-02
Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof
Grant 10,301,380 - West , et al.
2019-05-28
Modified Antibody Compositions, Methods Of Making And Using Thereof
App 20190119370 - Stagliano; Nancy Elizabeth ;   et al.
2019-04-25
Activatable Antibodies That Bind Epidermal Growth Factor Receptor And Methods Of Use Thereof
App 20180333507 - LOWMAN; Henry Bernard ;   et al.
2018-11-22
Modified antibody containing the cleavable peptide with the amino acid sequence TGRGPSWV
Grant 10,118,961 - Stagliano , et al. November 6, 2
2018-11-06
Cd147 Antibodies, Activatable Cd147 Antibodies, And Methods Of Making And Use Thereof
App 20180303952 - SAGERT; Jason Gary ;   et al.
2018-10-25
Anti-EGFR activatable antibodies
Grant 10,059,762 - Stagliano , et al. August 28, 2
2018-08-28
Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof
Grant 9,889,211 - Lowman , et al. February 13, 2
2018-02-13
Anti-jagged 1/jagged 2 Cross-reactive Antibodies, Activatable Anti-jagged Antibodies And Methods Of Use Thereof
App 20170298125 - West; James William ;   et al.
2017-10-19
Activatable Antibodies That Bind Epidermal Growth Factor Receptor And Methods Of Use Thereof
App 20170196996 - Lowman; Henry Bernard ;   et al.
2017-07-13
Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof
Grant 9,688,748 - West , et al. June 27, 2
2017-06-27
Modified Antibody Compositions, Methods Of Making And Using Thereof
App 20170081397 - Stagliano; Nancy E. ;   et al.
2017-03-23
Anti-pd1 Antibodies, Activatable Anti-pd1 Antibodies, And Methods Of Use Thereof
App 20170044259 - Tipton; Kimberly Ann ;   et al.
2017-02-16
Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof
Grant 9,545,442 - Lowman , et al. January 17, 2
2017-01-17
Activatable Antibodies That Bind Interleukin-6 Receptor And Methods Of Use Thereof
App 20170002082 - West; James William ;   et al.
2017-01-05
Anti-cd166 Antibodies, Activatable Anti-cd166 Antibodies, And Methods Of Use Thereof
App 20160355587 - West; James William ;   et al.
2016-12-08
Activatable antibodies that bind interleukin-6 receptor and methods of use thereof
Grant 9,487,590 - West , et al. November 8, 2
2016-11-08
Anti-pdl1 Antibodies, Activatable Anti-pdl1 Antibodies, And Methods Of Use Thereof
App 20160311903 - West; James William ;   et al.
2016-10-27
Matrix Metalloprotease-cleavable And Serine Protease-cleavable Substrates And Methods Of Use Thereof
App 20160289324 - Moore; Stephen James ;   et al.
2016-10-06
Protease-resistant Systems For Polypeptide Display And Methods Of Making And Using Thereof
App 20160264961 - La Porte; Sherry Lynn ;   et al.
2016-09-15
Modified Antibody Compositions, Methods Of Making And Using Thereof
App 20160228546 - Stagliano; Nancy Elizabeth ;   et al.
2016-08-11
Anti-Jagged 1/Jagged 2 Cross-Reactive Antibodies, Activatable Anti-Jagged Antibodies And Methods Of Use Thereof
App 20160200826 - West; James William ;   et al.
2016-07-14
Activatable Antibodies That Bind Epidermal Growth Factor Receptor And Methods Of Use Thereof
App 20160193332 - Lowman; Henry Bernard ;   et al.
2016-07-07
Protease-resistant systems for polypeptide display and methods of making and using thereof
Grant 9,309,510 - La Porte , et al. April 12, 2
2016-04-12
Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof
Grant 9,127,053 - West , et al. September 8, 2
2015-09-08
Activatable antibodies that bind epidermal growth factor receptor and methods of use thereof
Grant 9,120,853 - Lowman , et al. September 1, 2
2015-09-01
Multispecific Antibodies, Multispecific Activatable Antibodies And Methods Of Using The Same
App 20150079088 - Lowman; Henry Bernard ;   et al.
2015-03-19
Activatable Antibodies that Bind Interleukin-6 Receptor and Methods of Use Thereof
App 20140363430 - West; James William ;   et al.
2014-12-11
Protease-Resistant Systems for Polypeptide Display and Methods of Making and Using Thereof
App 20140235467 - La Porte; Sherry Lynn ;   et al.
2014-08-21
Anti-Jagged 1/Jagged 2 Cross-Reactive Antibodies, Activatable Anti-Jagged Antibodies And Methods Of Use Thereof
App 20140010810 - West; James William ;   et al.
2014-01-09
Activatable Antibodies That Bind Epidermal Growth Factor Receptor And Methods Of Use Thereof
App 20130315906 - Lowman; Henry Bernard ;   et al.
2013-11-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed